InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by LaFrence Andrew D.C.. Insider active across 2 companies, notably Vyant Bio, Inc.. Cumulatively, 8 reports have been recorded. Total volume traded: €52k. The latest transaction was disclosed on 23 November 2021 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
€8,8935,000 shares@ €1.778650.0% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-032696·
Ideal exit: 20 Aug 2022 (T+270)
€8,8935,000 shares@ €1.778620.4% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-032696:0·
Ideal exit: 20 Aug 2022 (T+270)
€8,8935,000 shares@ €1.778650.0% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-029829·
Ideal exit: 20 Aug 2022 (T+270)
€8,8935,000 shares@ €1.778620.4% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-029829:0·
Ideal exit: 20 Aug 2022 (T+270)
29,292 shares
Common Stock, $0.0001 par value
SEC:0001493152-21-016687·
29,292 shares
Common Stock, $0.0001 par value
SEC:0001493152-21-016687:0·
€8,0463,000 shares@ €2.6821100.0% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-012504·
Ideal exit: 14 Feb 2022 (T+270)
€8,0463,000 shares@ €2.682118.4% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-012504:0·
Ideal exit: 14 Feb 2022 (T+270)
8 of 8 declarations
About LaFrence Andrew D.C.
LaFrence Andrew D.C. is a director at Vyant Bio, Inc.
